Andlauer Healthcare Group Inc.
AND.TOTSXIndustrials
$54.97
+$0.00(+0.00%)
Market Cap$2.2B
P/E Ratio—
52W High$55.1
52W Low$36.68
Andlauer Healthcare Group Inc. (AND.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AND.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q3 FY2025Report Date: Jul 31, 2025EPS Actual
$0.34
Est. $0.42 · -18.8%
Revenue
$0.16B
Est. $0.17B · -5.3%
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Jul 31, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
AND.TO reports quarterly as a TSX-listed Integrated Freight & Logistics company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.49B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.49B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Apr 29, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Feb 24, 2026 | — | — | — | — | — | — |
| ◌ Q4 FY2025 | Nov 11, 2025 | $0.41 | — | — | — | $0.16B | — |
| ▼ Q3 FY2025 | Jul 31, 2025 | $0.42 | $0.34 | -18.8% | $0.16B | $0.17B | -5.3% |
| ▼ Q2 FY2025 | Apr 30, 2025 | $0.41 | $0.37 | -9.8% | $0.17B | $0.17B | -0.3% |
| ▼ Q1 FY2025 | Feb 26, 2025 | $0.46 | $0.44 | -4.3% | $0.17B | $0.17B | -1.6% |
| — Q4 FY2024 | Nov 5, 2024 | $0.41 | $0.41 | +0.0% | $0.16B | $0.17B | -6.4% |
| ▼ Q3 FY2024 | Jul 31, 2024 | $0.40 | $0.38 | -5.0% | $0.16B | $0.16B | -1.0% |
Q2 FY2026
Apr 29, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 24, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 11, 2025
EPS Actual
—
EPS Est.
$0.41
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 31, 2025Miss
EPS Actual
$0.34
EPS Est.
$0.42
EPS Surpr.
-18.8%
Revenue
$0.16B
Q2 FY2025
Apr 30, 2025Miss
EPS Actual
$0.37
EPS Est.
$0.41
EPS Surpr.
-9.8%
Revenue
$0.17B
Q1 FY2025
Feb 26, 2025Miss
EPS Actual
$0.44
EPS Est.
$0.46
EPS Surpr.
-4.3%
Revenue
$0.17B
Q4 FY2024
Nov 5, 2024
EPS Actual
$0.41
EPS Est.
$0.41
EPS Surpr.
+0.0%
Revenue
$0.16B
Q3 FY2024
Jul 31, 2024Miss
EPS Actual
$0.38
EPS Est.
$0.40
EPS Surpr.
-5.0%
Revenue
$0.16B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.49 | $0.49 | $0.49 | 1 |
| Q3 FY2027 | $0.46 | $0.46 | $0.46 | 1 |
| Q2 FY2027 | $0.47 | $0.47 | $0.47 | 1 |
| Q1 FY2027 | $0.44 | $0.44 | $0.44 | 1 |
| Q4 FY2026 | $0.63 | $0.63 | $0.63 | 1 |
| Q3 FY2026 | $0.55 | $0.55 | $0.55 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2025 | Jul 31, 2025 | -18.8% | $53.10 | $53.00 | -0.19% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -9.8% | $53.27 | $53.50 | +0.43% |
| ▼ Q1 FY2025 | Feb 26, 2025 | -4.3% | $45.37 | $45.11 | -0.57% |
| ▲ Q4 FY2024 | Nov 5, 2024 | +0.0% | $41.71 | $41.82 | +0.26% |
| ▼ Q3 FY2024 | Jul 31, 2024 | -5.0% | $41.20 | $40.94 | -0.63% |
| ▼ Q2 FY2024 | May 2, 2024 | -20.4% | $42.10 | $41.87 | -0.55% |
| ▲ Q1 FY2024 | Mar 5, 2024 | +4.8% | $39.27 | $39.01 | -0.66% |
| ▼ Q4 FY2023 | Nov 1, 2023 | -10.0% | $38.84 | $37.99 | -2.19% |
Q3 FY2025-0.19%
Report Date
Jul 31, 2025
EPS Beat/Miss
-18.8%
Price Before
$53.10
Price After
$53.00
Q2 FY2025+0.43%
Report Date
Apr 30, 2025
EPS Beat/Miss
-9.8%
Price Before
$53.27
Price After
$53.50
Q1 FY2025-0.57%
Report Date
Feb 26, 2025
EPS Beat/Miss
-4.3%
Price Before
$45.37
Price After
$45.11
Q4 FY2024+0.26%
Report Date
Nov 5, 2024
EPS Beat/Miss
+0.0%
Price Before
$41.71
Price After
$41.82
Q3 FY2024-0.63%
Report Date
Jul 31, 2024
EPS Beat/Miss
-5.0%
Price Before
$41.20
Price After
$40.94
Q2 FY2024-0.55%
Report Date
May 2, 2024
EPS Beat/Miss
-20.4%
Price Before
$42.10
Price After
$41.87
Q1 FY2024-0.66%
Report Date
Mar 5, 2024
EPS Beat/Miss
+4.8%
Price Before
$39.27
Price After
$39.01
Q4 FY2023-2.19%
Report Date
Nov 1, 2023
EPS Beat/Miss
-10.0%
Price Before
$38.84
Price After
$37.99
Avg Beat Reaction-0.20%
Avg Miss Reaction-0.62%
Beat Rate2 / 8 quarters
Largest Move-2.19% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AND.TO ends December
Andlauer Healthcare Group Inc. (AND.TO) most recently reported earnings on July 31, 2025 for Q3 FY2025, posting EPS of $0.34 — missing the analyst consensus of $0.42 by -18.8%. The next AND.TO earnings date is expected around September 1, 2026.
Each quarter, investors track AND.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AND.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AND.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AND.TO earnings · 5 questionsAndlauer Healthcare Group Inc.'s next earnings report is expected around September 1, 2026. AND.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AND.TO historically reports after market close (AMC).
AND.TO earnings datewhen is AND.TO earningsAND.TO next earnings datewhen does AND.TO report earningsAND.TO earnings calendar
▸ Source: FMP · Andlauer Healthcare Group Inc. SEC filings · US GAAP · Andlauer Healthcare Group Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026